Ancient drug could save NHS millions each year when treating older patients with heart conditions

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

Liquidia YUTREPIA inhalation powder gains FDA tentative approval

The Phase III INSPIRE trial served as the basis for the tentative approval. Credit: Sai Thaw Kyar/Shutterstock. Biopharmaceutical company Liquidia has received tentative approval from

August 20, 2024

Beckley Academy Welcomes New Faculty for 2024 Psychedelic Therapy Practitioners Courses | Psychedelic Invest

Beckley Academy, a leading training organization that prepares and trains practitioners with a focus on preparing mental health professionals to use ketamine, psilocybin, and MDMA

December 14, 2023

COVID-19 significantly raises risk of severe complications in pregnant women

Study found that pregnant mothers with COVID-19 face a significantly higher risk of severe maternal morbidity (SMM), including adult respiratory distress syndrome and acute renal

December 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.